Thursday marks the one-year anniversary of OpenAI's release of the public version of ChatGPT. The healthcare industry is still buzzing over the technology.
Health tech industry leaders saw the generative artificial intelligence text application as a possible game-changer almost immediately. ChatGPT, similar to other generative AI models, has the ability to automatically create content in response to user queries. While some decision-makers remain thrilled about the use in healthcare of ChatGPT—and generative AI more broadly—others are concerned about its potential to perpetuate racism and advance misinformation.
Read More: Dr. ChatGPT: A guide to generative AI in healthcare
Over the past 12 months, health system and insurance executives, digital health vendors, investors and others have poured resources into generative AI technology, with the goals of improving operations and clinical outcomes.
Health systems such as University of Rochester Medicine, Cleveland Clinic and UC San Diego Health are using the enterprise version of ChatGPT through Microsoft, which has invested a reported $13 billion into OpenAI. Electronic health record vendors such as Epic Systems and Oracle Health are adding generative AI capabilities. Google and Amazon are creating their own healthcare generative AI models to compete with Microsoft and OpenAI. Countless startups are promoting their generative AI capabilities, including Hippocratic AI, which is funded by major venture capital firms General Catalyst and Andreessen Horowitz.